
Medtronic (MDT) Stock Forecast & Price Target
Medtronic (MDT) Analyst Ratings
Bulls say
Medtronic is a strong investment opportunity due to its diverse portfolio, historical and projected financial performance, and progress in multiple areas such as product approvals and strategic investments for future growth. Despite short-term concerns such as competition and market conditions, MDT's strong fundamentals and positive outlook make it a compelling choice for investors. The company's stock has a Buy rating and is expected to continue its upward trajectory in the long term.
Bears say
Medtronic is facing several challenges in its major markets, notably in its Neurovascular and Neuromodulation segments, which have seen slower growth due to intense competition and limited innovation. Moreover, its recent M&A and strategic investments, while potentially driving future growth, also raise questions about the durability and confidence in its current products and technologies. Given these headwinds and uncertainties, the negative outlook on Medtronic's stock is warranted, with a potential decline in future revenues and potential risks to its P/E multiple expansion.
This aggregate rating is based on analysts' research of Medtronic and is not a guaranteed prediction by Public.com or investment advice.
Medtronic (MDT) Analyst Forecast & Price Prediction
Start investing in Medtronic (MDT)
Order type
Buy in
Order amount
Est. shares
0 shares